NASDAQ:ORIA Orion Biotech Opportunities (ORIA) Stock Price, News & Analysis → [BUY ALERT] Our #1 A.I. Stock for March (From Behind the Markets) (Ad) Free ORIA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$10.23▼$10.2350-Day Range$9.64▼$9.8052-Week Range$9.45▼$10.78Volume8 shsAverage Volume13,059 shsMarket Capitalization$263.42 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Orion Biotech Opportunities alerts: Email Address Ad Behind the Markets[BUY ALERT] Our #1 A.I. Stock for MarchIt's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.Get the name of the stock here - before it takes off >>> About Orion Biotech Opportunities Stock (NASDAQ:ORIA)Orion Biotech Opportunities Corp., a blank check company, intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities. The company was founded in 2021 and is based in New York, New York.Read More Ad Behind the Markets[BUY ALERT] Our #1 A.I. Stock for MarchIt's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.Get the name of the stock here - before it takes off >>> ORIA Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive ORIA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Orion Biotech Opportunities and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today3/28/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorUnclassified Industry Holding & other investment offices Sub-IndustryN/A Current SymbolNASDAQ:ORIA CUSIPN/A CIK1847416 Weborionbiotechopportunities.com Phone213-303-1650FaxN/AEmployees2,021Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$8.76 million Net MarginsN/A Pretax MarginN/A Return on Equity-110.40% Return on Assets4.34% Debt Debt-to-Equity RatioN/A Current Ratio6.49 Quick Ratio6.49 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash Flow$0.34 per share Price / Cash Flow30.08 Book Value($0.30) per share Price / Book-34.10Miscellaneous Outstanding Shares25,750,000Free Float25,132,000Market Cap$263.42 million OptionableNot Optionable Beta-0.01 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMr. Zuie-Chin Huang M.B.A. (Age 56)CEO & Director Mr. Mark Kayal (Age 37)CFO & Sec. Mr. Robert Kenneth Simonds (Age 48)Gen. Counsel, Assistant Sec., VP & Director Key CompetitorsFTAC Emerald AcquisitionNASDAQ:EMLDDA32 Life Science Tech AcquisitionNASDAQ:DALSExecutive Network PartneringNYSE:ENPCPearl Holdings AcquisitionNASDAQ:PRLHPatria Latin American Opportunity AcquisitionNASDAQ:PLAOView All Competitors This page (NASDAQ:ORIA) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the Markets“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Orion Biotech Opportunities Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.